Page 14 - Roche Diagnostics News Today

In this article, Roche outlines a novel method by which one can streamline their KAPA RNA workflowsthrough the utilization of ribodepletion.

In 2023, the Tissue-Based Genomic Profiling Market is expected to be worth US$ 1.2 billion. The market is expected to reach US$ 2.2 billion by 2033, expanding at a 6.6% CAGR throughout the forecast period. In recent years, the market for tissue-based genetic profiling has grown significantly. The market is likely to...

The U.S. Food and Drug Administration (FDA) issues safety alerts as needed to provide timely new safety information on human drugs, medical devices, vaccines, and other products, including biologics, dietary supplements, and cosmetics. The alerts are publicly available at the agency’s MedWatch website and contain “actionable information that may impact both treatment and diagnostic choices […]

The cobas® connection modules (CCM) sample conveyors system has been extended with newly developed elevator and overhead conveyor modules enabling more flexibility in lab design.CCM Vertical optimises the use of

/PRNewswire/ -- Roche announced today that it has a new addition to the cobas® connection modules (CCM), the CCM Vertical, allowing transportation of samples...

Researchers in Scotland have struck a deal with a major pharmaceutical company to develop blood tests which could detect Alzheimers disease in the…

Scottish Brain Sciences is collaborating with Roche Diagnostics on the project.

Scottish Brain Sciences is collaborating with Roche Diagnostics on the project.

Scottish Brain Sciences is collaborating with Roche Diagnostics on the project.

Scottish Brain Sciences has teamed up with Roche Diagnostics on a series of major projects.